Coagulation markers such as D‐dimer, thrombin–antithrombin complex (TAT), and thrombomodulin (TM) show a potential predictive value for cancer‐associated VTE but lack extensive research in NHL. Here, THBD is linked to non-Hodgkin lymphoma.